| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A D Snyder, E Zuniga, L Ma, J L Steinberg, K Woisard, P A Narayana, S Lane, J Schmitz, F G Moelle. Examination of preliminary behavioral and effective connectivity findings from treatment response to citalopram in cocaine use disorder: A dynamic causal modeling study. Psychiatry research. Neuroimaging. vol 303. 2020-12-14. PMID:32593950. |
we sought effective (directional) connectivity parameters associated with response to citalopram in cocaine use disorder (cud) by conducting a functional magnetic resonance imaging (fmri) experiment with participants diagnosed with cud (n = 13) and matched healthy controls (hc; n = 17). |
2020-12-14 |
2023-08-13 |
human |
| André de Queiroz Constantino Miguel, Clarice Sandi Madruga, Viviane Simões, Rodolfo Yamauchi, Claudio Jerônimo da Silva, Michael McDonell, Sterling McPherson, John Roll, Ronaldo Ramos Laranjeira, Jair de Jesus Mar. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users with a previous history of poor treatment response: a crossover trial. Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS. vol 32. issue 1. 2020-11-12. PMID:32026092. |
contingency management has shown robust evidence of efficacy in the treatment of cocaine use disorder (cud) in high-income countries; however, it is still unclear how this intervention can impact treatment in low-income countries. |
2020-11-12 |
2023-08-13 |
Not clear |
| Frances R Levin, John J Mariani, Martina Pavlicova, C Jean Choi, Amy L Mahony, Daniel J Brooks, Adam Bisaga, Elias Dakwar, Kenneth M Carpenter, Nasir Naqvi, Edward V Nunes, Kyle Kampma. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and alcohol dependence. vol 206. 2020-11-09. PMID:31753736. |
cocaine use disorder (cud) remains a substantial public health problem with no clearly effective pharmacotherapy available. |
2020-11-09 |
2023-08-13 |
Not clear |
| Pedro Araos, Rebeca Vidal, Esther O'Shea, María Pedraz, Nuria García-Marchena, Antonia Serrano, Juan Suárez, Estela Castilla-Ortega, Juan Jesús Ruiz, Rafael Campos-Cloute, Luis J Santín, Fernando Rodríguez de Fonseca, Francisco Javier Pavón, María Isabel Colad. Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients. Scientific reports. vol 9. issue 1. 2020-11-02. PMID:31727978. |
abstinent patients with cocaine use disorder (cud) and control subjects were recruited for a cross-sectional study. |
2020-11-02 |
2023-08-13 |
human |
| Luis J Gómez Pérez, Stefano Cardullo, Nicola Cellini, Michela Sarlo, Tommaso Monteanni, Antonello Bonci, Alberto Terraneo, Luigi Gallimberti, Graziella Made. Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study. BMC psychiatry. vol 20. issue 1. 2020-10-29. PMID:32252720. |
sleep disturbance is a prominent and common complaint in people with cocaine use disorder (cud), either during intake or withdrawal. |
2020-10-29 |
2023-08-13 |
Not clear |
| Luis J Gómez Pérez, Stefano Cardullo, Nicola Cellini, Michela Sarlo, Tommaso Monteanni, Antonello Bonci, Alberto Terraneo, Luigi Gallimberti, Graziella Made. Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study. BMC psychiatry. vol 20. issue 1. 2020-10-29. PMID:32252720. |
thus, we evaluated the relationship between self-perceived sleep quality and cocaine use pattern variables in outpatients with cud undergoing an rtms protocol targeted at the left dorsolateral prefrontal cortex. |
2020-10-29 |
2023-08-13 |
Not clear |
| Ernest T Chivero, Rizwan Ahmad, Annadurai Thangaraj, Palsamy Periyasamy, Balawant Kumar, Elisa Kroeger, Dan Feng, Ming-Lei Guo, Sabita Roy, Punita Dhawan, Amar B Singh, Shilpa Buc. Cocaine Induces Inflammatory Gut Milieu by Compromising the Mucosal Barrier Integrity and Altering the Gut Microbiota Colonization. Scientific reports. vol 9. issue 1. 2020-10-22. PMID:31434922. |
cocaine use disorder (cud), a major health crisis, has traditionally been considered a complication of the cns; however, it is also closely associated with malnourishment and deteriorating gut health. |
2020-10-22 |
2023-08-13 |
mouse |
| Brian J Sherman, Nathaniel L Baker, Kathleen T Brady, Jane E Joseph, Lisa M Nunn, Aimee McRae-Clar. The effect of oxytocin, gender, and ovarian hormones on stress reactivity in individuals with cocaine use disorder. Psychopharmacology. vol 237. issue 7. 2020-10-20. PMID:32388622. |
cocaine use disorder (cud) is associated with dysregulation of the hypothalamic-pituitary-adrenal axis, which plays a critical role in the human stress response. |
2020-10-20 |
2023-08-13 |
human |
| Ying Jiang, Azizi Ray, Mohammad Shajid Ashraf Junaid, Sonalika Arup Bhattaccharjee, Kayla Kelley, Ajay K Banga, Bruce E Blough, Kevin S Murnan. The pharmacokinetics of 3-fluoroamphetamine following delivery using clinically relevant routes of administration. Drug delivery and translational research. vol 10. issue 1. 2020-10-05. PMID:31642004. |
3-fluoroamphetamine (also called pal-353) is a synthetic amphetamine analog that has been investigated for cocaine use disorder (cud), yet no studies have characterized its pharmacokinetics (pk). |
2020-10-05 |
2023-08-13 |
rat |
| Christopher S Stauffer, Vivek Musinipally, Angela Suen, Kara L Lynch, Brad Shapiro, Joshua D Woolle. A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction research & theory. vol 24. issue 6. 2020-10-01. PMID:28503120. |
cocaine use disorder (cud) has no fda-approved pharmacological treatment; existing psychosocial treatments are inadequate. |
2020-10-01 |
2023-08-13 |
Not clear |
| Rosa Maza-Quiroga, Nuria García-Marchena, Pablo Romero-Sanchiz, Vicente Barrios, María Pedraz, Antonia Serrano, Raquel Nogueira-Arjona, Juan Jesus Ruiz, Maribel Soria, Rafael Campos, Julie Ann Chowen, Jesus Argente, Marta Torrens, Meritxell López-Gallardo, Eva María Marco, Fernando Rodríguez de Fonseca, Francisco Javier Pavón, Pedro Arao. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis. PeerJ. vol 5. 2020-10-01. PMID:29038767. |
cocaine use disorder (cud) is a complex health condition, especially when it is accompanied by comorbid psychiatric disorders (dual diagnosis). |
2020-10-01 |
2023-08-13 |
Not clear |
| John Marsden, Camille Goetz, Tim Meynen, Luke Mitcheson, Garry Stillwell, Brian Eastwood, John Strang, Nick Gre. Memory-focused cognitive therapy for cocaine use disorder: Rationale, design and protocol for an external pilot randomised controlled trial. Contemporary clinical trials communications. vol 8. 2020-10-01. PMID:29696218. |
cocaine use disorder (cud) is a debilitating condition characterised by maladaptive cocaine-related memories and impaired cognitive and behavioural control. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jane E Joseph, Brandon K Vaughan, Christopher C Camp, Nathaniel L Baker, Brian J Sherman, Megan Moran-Santa Maria, Aimee McRae-Clark, Kathleen T Brad. Oxytocin-Induced Changes in Intrinsic Network Connectivity in Cocaine Use Disorder: Modulation by Gender, Childhood Trauma, and Years of Use. Frontiers in psychiatry. vol 10. 2020-10-01. PMID:31379621. |
cocaine use disorder (cud) is a major public health concern with devastating social, economic, and mental health implications. |
2020-10-01 |
2023-08-13 |
Not clear |
| Benjamin Keller, Joan-Ignasi Mestre-Pinto, María Álvaro-Bartolomé, Diana Martinez-Sanvisens, Magí Farre, M Julia García-Fuster, Jesús A García-Sevilla, Marta Torren. A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I Frontiers in psychiatry. vol 8. 2020-09-30. PMID:29326609. |
a biomarker to differentiate between primary and cocaine-induced major depression in cocaine use disorder: the role of platelet iras/nischarin (i the association of cocaine use disorder (cud) and comorbid major depressive disorder (mdd; cud/mdd) is characterized by high prevalence and poor treatment outcomes. |
2020-09-30 |
2023-08-13 |
Not clear |
| James M Kasper, Ashley E Smith, Jonathan D Homme. Cocaine-Evoked Locomotor Activity Negatively Correlates With the Expression of Neuromedin U Receptor 2 in the Nucleus Accumbens. Frontiers in behavioral neuroscience. vol 12. 2020-09-30. PMID:30483076. |
cocaine use disorder (cud) is characterized by repeated cycles of drug seeking and drug taking. |
2020-09-30 |
2023-08-13 |
rat |
| Angela Sanna, Liana Fattore, Paola Badas, Giorgio Corona, Viola Cocco, Marco Dian. Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Cocaine Use Disorder: A Pilot Study. Frontiers in neuroscience. vol 13. 2020-09-30. PMID:31402851. |
transcranial magnetic stimulation (tms) is earning a role in the therapeutic arsenal of cocaine use disorder (cud). |
2020-09-30 |
2023-08-13 |
Not clear |
| Elise E DeVito, Aryeh I Herman, Noah S Konkus, Huiping Zhang, Mehmet Sofuogl. Atomoxetine in abstinent cocaine users: Sex differences. Data in brief. vol 14. 2020-09-29. PMID:28861456. |
data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (cud). |
2020-09-29 |
2023-08-13 |
human |
| Vaughn R Steele, Andrea M Maxwell, Thomas J Ross, Elliot A Stein, Betty Jo Salmero. Accelerated Intermittent Theta-Burst Stimulation as a Treatment for Cocaine Use Disorder: A Proof-of-Concept Study. Frontiers in neuroscience. vol 13. 2020-09-29. PMID:31736689. |
there are no effective treatments for cocaine use disorder (cud), a chronic, relapsing brain disease characterized by dysregulated circuits related to cue reactivity, reward processing, response inhibition, and executive control. |
2020-09-29 |
2023-08-13 |
human |
| Stefano Cardullo, Luis Javier Gomez Perez, Linda Marconi, Alberto Terraneo, Luigi Gallimberti, Antonello Bonci, Graziella Made. Clinical Improvements in Comorbid Gambling/Cocaine Use Disorder (GD/CUD) Patients Undergoing Repetitive Transcranial Magnetic Stimulation (rTMS). Journal of clinical medicine. vol 8. issue 6. 2020-09-28. PMID:31151221. |
(1) background: pathological gambling behaviors may coexist with cocaine use disorder (cud), underlying common pathogenic mechanisms. |
2020-09-28 |
2023-08-13 |
Not clear |
| Stefano Cardullo, Luis Javier Gomez Perez, Linda Marconi, Alberto Terraneo, Luigi Gallimberti, Antonello Bonci, Graziella Made. Clinical Improvements in Comorbid Gambling/Cocaine Use Disorder (GD/CUD) Patients Undergoing Repetitive Transcranial Magnetic Stimulation (rTMS). Journal of clinical medicine. vol 8. issue 6. 2020-09-28. PMID:31151221. |
(2) methods: gambling severity, craving for cocaine, sleep, and other negative affect symptoms were recorded in seven patients with a diagnosis of gambling disorder (south oaks gambling screen (sogs) >5), in comorbidity with cud, using the following scales: gambling-symptom assessment scale (g-sas), cocaine craving questionnaire (ccq), beck depression inventory-ii (bdi-ii), self-rating anxiety scale (sas), and symptoms checklist-90 (scl-90). |
2020-09-28 |
2023-08-13 |
Not clear |